Citation Impact
Citing Papers
TGF-β signaling in the control of hematopoietic stem cells
2015
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin
2015
Tornado extraction: A method to enrich and purify RNA from the nephrogenic zone of the neonatal rat kidney
2002 StandoutNobel
Pharmacotherapy of type 2 diabetes: An update
2017
Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice
2006 StandoutNobel
Regulation of the Voltage Gated K<sup>+</sup> Channel K<sub>v1.3</sub> by Recombinant Human Klotho Protein
2014 Standout
Fracture healing in the elderly patient
2006
Dimerization in the absence of higher-order oligomerization of the G protein-coupled secretin receptor
2008
α2-HS Glycoprotein/Fetuin, a Transforming Growth Factor-β/Bone Morphogenetic Protein Antagonist, Regulates Postnatal Bone Growth and Remodeling
2002
Gi-Coupled GPCR Signaling Controls the Formation and Organization of Human Pluripotent Colonies
2009 StandoutNobel
Recent advances in physiological calcium homeostasis
2006
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Pathogenesis of osteoporosis
2003
TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
2009 Standout
Ligand-regulated oligomerization of β2-adrenoceptors in a model lipid bilayer
2009 StandoutNobel
Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial
2012
Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function
2004
Elevated serum level and gene polymorphisms of TGF‐β1 in gastric cancer
2008
G Protein-coupled Receptor Kinase Regulates Dopamine D3 Receptor Signaling by Modulating the Stability of a Receptor-Filamin-β-Arrestin Complex
2005
The efficacy and safety of DPP4 inhibitors compared to sulfonylureas as add-on therapy to metformin in patients with Type 2 diabetes: A systematic review and meta-analysis
2015
Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis
2012
Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis, and hemodialysis: A comparative analysis
1999
Molecular changes in bone collagen in osteoporosis and osteoarthritis in the elderly
1999
Cancer-associated cachexia
2018 Standout
Gastrointestinal Adverse Events of Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-analysis
2017
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review
2012
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
2013 Standout
Distinct effects of PPARγ insufficiency on bone marrow cells, osteoblasts, and osteoclastic cells
2005
The structure and function of G-protein-coupled receptors
2009 StandoutNatureNobel
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
Osteoporosis, inflammation and ageing
2005
Interleukin‐6 maintains bone marrow‐derived mesenchymal stem cell stemness by an ERK1/2‐dependent mechanism
2009
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
GPCR modulation by RAMPs
2005
Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies
2016
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Is prostate-specific membrane antigen a multifunctional protein?
2005
Small molecule drug screening in Drosophila identifies the 5HT2A receptor as a feeding modulation target
2013 Standout
The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
2003 Standout
Differential targeting and function of α2A and α2C adrenergic receptor subtypes in cultured sympathetic neurons
2006 StandoutNobel
TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology
2016 Standout
Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy
2000
Adipocyte differentiation from the inside out
2006 Standout
The role of senescent cells in ageing
2014 StandoutNature
Type 2 diabetes mellitus
2015 Standout
The Hallmarks of Aging
2013 Standout
Osteocytes inhibit osteoclastic bone resorption through transforming growth factor‐β: Enhancement by estrogen*
2002
Physical Activity in the Prevention and Amelioration of Osteoporosis in Women
2005
Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients
2002
Receptor Activity-modifying Proteins 2 and 3 Have Distinct Physiological Functions from Embryogenesis to Old Age
2007 StandoutNobel
Muscles, exercise and obesity: skeletal muscle as a secretory organ
2012 Standout
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons
2012
Regulation of Osteogenesis by Fetuin
1999
Adipose Tissue as an Endocrine Organ
2004 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
New Roles for β-Arrestins in Cell Signaling: Not Just for Seven-Transmembrane Receptors
2006 StandoutNobel
2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial
2012
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
The Complex Role of Estrogens in Inflammation
2007 Standout
Graphene Oxide: Preparation, Functionalization, and Electrochemical Applications
2012 Standout
Synthesis of Light-Emitting Conjugated Polymers for Applications in Electroluminescent Devices
2009 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Aging, Cellular Senescence, and Cancer
2012 Standout
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors
2017
The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: a systematic review and meta‐analysis
2013
Direct head‐to‐head comparison of glycaemic durability of dipeptidyl peptidase‐4 inhibitors and sulphonylureas in patients with type 2 diabetes mellitus: A meta‐analysis of long‐term randomized controlled trials
2017
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis
2016
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Roles of Protein Kinase C and Actin-Binding Protein 280 in the Regulation of Intracellular Trafficking of Dopamine D3 Receptor
2007
β-Arrestin- and G Protein Receptor Kinase-Mediated Calcium-Sensing Receptor Desensitization
2005
Regulation of GPCRs by Endocytic Membrane Trafficking and Its Potential Implications
2007
Electrochemiluminescence (ECL)
2004 Standout
A randomized clinical trial evaluating the safety and efficacy of sitagliptin added to the combination of sulfonylurea and metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
2015
Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta‐analysis
2013
Transforming Growth Factor-β1 to the Bone
2005
Changes in Proinflammatory Cytokine Activity after Menopause
2002
Inhibition of TGF-β receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass
1999
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes
2015
Glycaemic durability with dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of long-term randomised controlled trials
2014
ECL—Electrochemical luminescence
2007
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Superoxide Ion: Generation and Chemical Implications
2016 Standout
Safety and efficacy of dipeptidyl peptidase-4 inhibitors vs sulfonylurea in metformin-based combination therapy for type 2 diabetes mellitus: Systematic review and meta-analysis
2016
Electrogenerated Chemiluminescence and Its Biorelated Applications
2008 Standout
A β-Arrestin–Biased Agonist of the Parathyroid Hormone Receptor (PTH1R) Promotes Bone Formation Independent of G Protein Activation
2009 StandoutNobel
How Matrix Metalloproteinases Regulate Cell Behavior
2001 Standout
Transforming growth factor β (TGF-β) levels in the conditioned media of human bone cells: relationship to donor age, bone volume, and concentration of TGF-β in human bone matrix in vivo
1999
The amazing osteocyte
2010 Standout
Trafficking of G Protein–Coupled Receptors
2006 StandoutNobel
Membrane Trafficking of G Protein–Coupled Receptors
2004
A review of dipeptidyl peptidase‐4 inhibitors. Hot topics from randomized controlled trials
2018
UV Radiation and the Skin
2013 Standout
Head‐to‐head comparison of dipeptidyl peptidase‐IV inhibitors and sulfonylureas – a meta‐analysis from randomized clinical trials
2013
Cardiovascular safety of sulfonylureas: a meta‐analysis of randomized clinical trials
2013
Sensing the Environment: Regulation of Local and Global Homeostasis by the Skin's Neuroendocrine System
2012
Works of Thomas Seck being referenced
Compliance and persistence with concomitant statin and oral antihyperglycemic therapy.
2011
Sitagliptin more effectively achieves a composite endpoint for A1C reduction, lack of hypoglycemia and no body weight gain compared with glipizide
2011
Expression of Interleukin-6 (IL-6) and IL-6 receptor mRNA in human bone samples from pre- and postmenopausal women
2002
Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double‐blind, non‐inferiority trial
2010
Assessment of AACE/ACE Recommendations for Initial Dual Antihyperglycemic Therapy Using the Fixed-Dose Combination of Sitagliptin and Metformin Versus Metformin
2013
The Alternatively Spliced Δe13 Transcript of the Rabbit Calcitonin Receptor Dimerizes with the C1a Isoform and Inhibits Its Surface Expression
2003
Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study
2010
Safety and Tolerability of Linagliptin in Patients With Type 2 Diabetes: A Comprehensive Pooled Analysis of 22 Placebo-controlled Studies
2014
Leptin concentrations in serum from a randomly recruited sample of 50- to 80-year-old men and women: positive association with plasma insulin-like growth factors (IGFs) and IGF-binding protein-3 in lean, but not in obese, individuals
1998
A one‐year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes
2009
Association of Transforming Growth Factor-b1 (TGFb1) T29?C Gene Polymorphism with Bone Mineral Density (BMD), Changes in BMD, and Serum Concentrations of TGF-b1 in a Population-Based Sample of Postmenopausal German Women
2001
Low serum concentrations of insulin‐like growth factor I are associated with femoral bone loss in a population‐based sample of postmenopausal women
2001
Cardiovascular safety of linagliptin in type 2 diabetes: a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular events
2015
A treatment strategy implementing combination therapy with sitagliptin and metformin results in superior glycaemic control versus metformin monotherapy due to a low rate of addition of antihyperglycaemic agents
2011
Binding of Filamin to the C-terminal Tail of the Calcitonin Receptor Controls Recycling
2003
Serum parathyroid hormone, but not menopausal status, is associated with the expression of osteoprotegerin and RANKL mRNA in human bone samples
2001
The effect of initial therapy with the fixed‐dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus
2011
The Δe13 Isoform of the Calcitonin Receptor Forms a Six-Transmembrane Domain Receptor with Dominant-Negative Effects on Receptor Surface Expression and Signaling
2005
Sitagliptin compared with the Sulfonylurea Glimepiride provides similar efficacy with less Hypoglycemia and no weight gain when added to ongoing Metformin therapy in patients with Type 2 Diabetes Mellitus (T2DM)
2010
Concentration of Transforming Growth Factor Beta in Human Bone Tissue: Relationship to Age, Menopause, Bone Turnover, and Bone Volume
1998
Concentration of Insulin-Like Growth Factor (IGF)-I and -II in Iliac Crest Bone Matrix from Pre- and Postmenopausal Women: Relationship to Age, Menopause, Bone Turnover, Bone Volume, and Circulating IGFs
1998
Concentration of Insulin-Like Growth Factor (IGF)-I and -II in Iliac Crest Bone Matrix from Pre- and Postmenopausal Women: Relationship to Age, Menopause, Bone Turnover, Bone Volume, and Circulating IGFs1
1998